PM
NGNE icon

Prosight Management’s Neurogene NGNE Stock Holding History

Prosight Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,319
Closed -$797K – 52
2020
Q3 		$797K Buy
+3,319
New +$804K 0.38% 41
2019
Q3 		– Sell
-182
Closed -$9K – 43
2019
Q2 		$9K Sell
182
-1,233
-87% -$63.4K ﹤0.01% 39
2019
Q1 		$76K Sell
1,415
-2,599
-65% -$131K 0.03% 37
2018
Q4 		$173K Buy
4,014
+1,181
+42% +$57.5K 0.09% 35
2018
Q3 		$166K Sell
2,833
-17,212
-86% -$1.02M 0.09% 32
2018
Q2 		$1.06M Buy
+20,045
New +$5.22M 0.78% 25

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management's NGNE Position: Q4 2020 in Review

Prosight Management sold out of Neurogene (NGNE) in Q4 2020, closing a stake of 3,319 shares — an estimated $797K sold.

Prosight Management first reported a position in NGNE in Q2 2018 and held it in 6 quarters. The position peaked at $1.06M in Q2 2018. 84 funds tracked by Wall St. Rank hold NGNE as of Q4 2020.

  • Prosight Management reported no remaining Neurogene position as of Q4 2020 after selling out during the quarter.
  • Prosight Management sold 3,319 Neurogene shares in Q4 2020, an estimated $797K.
  • Prosight Management first reported a position in Neurogene in Q2 2018 and held it in 6 quarters.
  • Prosight Management's Neurogene position peaked at $1.06M in Q2 2018.
  • 84 funds tracked by Wall St. Rank held Neurogene as of Q4 2020.

Based on Prosight Management's 13F filing for Q4 2020, filed 12 Feb 2021.